Virology Products & Services

Tools and expert services for vaccine and therapeutic antibody developers

Critical virology reagents

20+ years virology expertise

Trusted by 100+ labs

Explore: Visit Our New Dedicated Virology Website

We’ve grown our Virology product and service offerings so much we needed a new website to hold everything! The Virology at Integral Molecular website offers an improved browsing experience, including:

  • Streamlined ordering by credit card or purchase order
  • Enhanced product pages and technical information

Quick links

As always, our experts are available to answer your questions and discuss your project needs. Contact us any time.

Virology at Integral Molecular: Experience and Quality You Can Rely On

Founded by virologists in 2001, Integral Molecular is an experienced provider of virology reagents and services. We understand viruses from basic mechanisms to assay development, and virology remains at the core of everything we do.

Through our Virology business unit, we support scientists working to understand and combat diverse viruses, including influenza, SARS-CoV-2, dengue, Zika, Chikungunya, Ebola, Marburg, Nipah, and more. Learn more about how our expertise and products can support your projects.

The Integral Advantage: What Sets Us Apart

Expertise

Our team is known for its rapid responses to new outbreaks and evolving customer needs. We are passionate about providing high-quality and customizable reagents that enable scientifically impactful work.

Quality

Because assays should be reliable and useful, we invest our time in making products that work well in your hands. To see our ISO 9001 certificate and a full description of our commitment to quality, visit our Quality page.

Customer Experience

Your success is our priority, and we work hard to understand your needs. You get the products and services you expect, when you expect them.

Trusted by 100+ Laboratories for R&D and Clinical Trials ​

We have used our virology expertise to serve over 100 labs. Learn about some of our customers’ successes, including case studies and publications, on our Virology Resources page.

Ready To Get Started?

We have worked with more than 100 top biotech and pharmaceutical companies to help them succeed. Let’s talk about how we can help you.

Or call (215) 966-6061

Virology at Integral Molecular: Experience and Quality You Can Rely On

Integral Molecular is an experienced provider of virology reagents and services. We support scientists working to understand and combat diverse viruses, including influenza, SARS-CoV-2, dengue, Zika, Chikungunya, Ebola, Marburg, Nipah, and more.

Our flagship product is Reporter Virus Particles (RVPs). These non-replicative particles are a safe, ready-to-use substitute for live virus in infectivity and neutralization assays.

Explore: Virology Products & Services

Pseudotyped viral particles for safe, easy neutralization assays
Ready-to-use influenza reagent for easier hemagglutination inhibition (HAI) assays
For antibody developers who need neutralization data

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Custom pseudoviruses with the surface proteins and reporter of your choice

"Quick and detailed responses to questions and helpful suggestions offered when troubleshooting the assay."

Trusted by 100+ Laboratories for R&D and Clinical Trials ​

Logos of companies that have done case studies.

The Integral Advantage: What Sets Us Apart

An icon showing expertise.
Expertise

Integral Molecular was founded by virologists in 2001. We understand viruses from basic mechanisms to assay development. From Epitope Mapping to Lipoparticles and beyond, virology remains at the core of everything we do.

Our quality web icon.
Quality

Because assays should be reliable and useful, we invest our time in making products that work well in your hands. To see our ISO 9001 certificate and a full description of our commitment to quality, please visit our Quality page.

Customer experience web icon.
Customer Experience
Your success is our priority, and we work hard to understand your needs. You get the products and services you expect, when you expect them.

“SARS-CoV-2 RVPs really helped us a lot since we did not have much previous expertise in SARS. The user meetings were especially helpful.”

Featured Publications

To see more publications, plus case studies and webinars, visit the Resources page

Order our virology reagents through our click-to-purchase website or through our partner distributors.

Scientist.com logo.
KRISHGEN Bio Systems logo.
Funakoshi logo.
Sung Woo logo.

Frequently Asked Questions

RVPs incorporate virus-specific envelope proteins that are antigenically equivalent to those of live wild-type viruses. They contain a modified genome and so are replication-incompetent and safe to use under standard safety levels (BSL-2). Once the RVPs are in your hands, you can begin your neutralization assays immediately – no need for growing and sequencing live virus.
RVPs are used for infectivity and neutralization assays, and are ideal for use in high-throughput assay formats. They are a safe (BSL-2) and efficient alternative to live virus plaque or microneutralization assays. Many customers use our RVPs to conduct sera neutralization assays to assess efficacy of their vaccine or vaccine candidate.
Luciferase and GFP are used for quantitative readouts.

Integral Molecular offers many vaccine development solutions including the production of reporter viruses, epitope mapping on viral targets, protein engineering for vaccine discovery, and antibody discovery against viral targets.

Yes. We can produce custom RVPs to accelerate your vaccine or antibody development project, with variants of current RVPs, or for a virus of your choice. We have a team of expert scientists that acts as your partner from project initiation to delivery of RVPs. Our customized quality control services and reports meet the specific needs of your team and project.

Yes. We can produce large lots of RVPs to accommodate screening 100s or 1000s of samples in sera neutralization assays without bridging studies.

Contact Us for More Information